ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nanotechnology Drug Delivery Systems Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-20T12594
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Nanotechnology Drug Delivery Systems Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Nanotechnology Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-20T12594
Report
June 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Amgen Inc
Celgene Corporation
Johnson & Johnson
Merck& Co. Inc
Novartis International AG
Perrigo Company plc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG

Nanotechnology Drug Delivery Systems Market Size

The global market for Nanotechnology Drug Delivery Systems was valued at US$ 4780 million in the year 2024 and is projected to reach a revised size of US$ 5668 million by 2031, growing at a CAGR of 2.5% during the forecast period.

Nanotechnology Drug Delivery Systems Market

Nanotechnology Drug Delivery Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nanotechnology Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology Drug Delivery Systems.
The Nanotechnology Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanotechnology Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanotechnology Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nanotechnology Drug Delivery Systems Market Report

Report Metric Details
Report Name Nanotechnology Drug Delivery Systems Market
Accounted market size in year US$ 4780 million
Forecasted market size in 2031 US$ 5668 million
CAGR 2.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nanotechnology Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanotechnology Drug Delivery Systems Market growing?

Ans: The Nanotechnology Drug Delivery Systems Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the Nanotechnology Drug Delivery Systems Market size in 2031?

Ans: The Nanotechnology Drug Delivery Systems Market size in 2031 will be US$ 5668 million.

Who are the main players in the Nanotechnology Drug Delivery Systems Market report?

Ans: The main players in the Nanotechnology Drug Delivery Systems Market are AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG

What are the Application segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Applications covered in the Nanotechnology Drug Delivery Systems Market report are Immunology, Cardiovascular, Neurology, Oncology, Others

What are the Type segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Types covered in the Nanotechnology Drug Delivery Systems Market report are Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others

Recommended Reports

Drug Delivery Technologies

Specialized Delivery Devices

Ocular and Microneedle Systems

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nanocrystals
1.2.3 Nanoparticles
1.2.4 Dendrimers
1.2.5 Gold Nanoparticles
1.2.6 Fullerenes
1.2.7 Liposomes
1.2.8 Nanotubes
1.2.9 Others
1.3 Market by Application
1.3.1 Global Nanotechnology Drug Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunology
1.3.3 Cardiovascular
1.3.4 Neurology
1.3.5 Oncology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology Drug Delivery Systems Market Perspective (2020-2031)
2.2 Global Nanotechnology Drug Delivery Systems Growth Trends by Region
2.2.1 Global Nanotechnology Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nanotechnology Drug Delivery Systems Historic Market Size by Region (2020-2025)
2.2.3 Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2026-2031)
2.3 Nanotechnology Drug Delivery Systems Market Dynamics
2.3.1 Nanotechnology Drug Delivery Systems Industry Trends
2.3.2 Nanotechnology Drug Delivery Systems Market Drivers
2.3.3 Nanotechnology Drug Delivery Systems Market Challenges
2.3.4 Nanotechnology Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue
3.1.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue (2020-2025)
3.1.2 Global Nanotechnology Drug Delivery Systems Revenue Market Share by Players (2020-2025)
3.2 Global Nanotechnology Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nanotechnology Drug Delivery Systems Revenue
3.4 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Systems Revenue in 2024
3.5 Global Key Players of Nanotechnology Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application
3.7 Global Key Players of Nanotechnology Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology Drug Delivery Systems Breakdown Data by Type
4.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Type (2020-2025)
4.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2026-2031)
5 Nanotechnology Drug Delivery Systems Breakdown Data by Application
5.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Application (2020-2025)
5.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nanotechnology Drug Delivery Systems Market Size (2020-2031)
6.2 North America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)
6.4 North America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanotechnology Drug Delivery Systems Market Size (2020-2031)
7.2 Europe Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)
7.4 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size (2020-2031)
8.2 Asia-Pacific Nanotechnology Drug Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025)
8.4 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanotechnology Drug Delivery Systems Market Size (2020-2031)
9.2 Latin America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)
9.4 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size (2020-2031)
10.2 Middle East & Africa Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)
10.4 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Details
11.1.2 AbbVie, Inc. Business Overview
11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Introduction
11.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.1.5 AbbVie, Inc. Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Introduction
11.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.2.5 Amgen Inc. Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Introduction
11.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.3.5 Celgene Corporation Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Introduction
11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Introduction
11.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Novartis International AG
11.6.1 Novartis International AG Company Details
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Introduction
11.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.6.5 Novartis International AG Recent Development
11.7 Perrigo Company plc
11.7.1 Perrigo Company plc Company Details
11.7.2 Perrigo Company plc Business Overview
11.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Introduction
11.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.7.5 Perrigo Company plc Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Details
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Introduction
11.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.8.5 Pfizer, Inc. Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 3M
11.10.1 3M Company Details
11.10.2 3M Business Overview
11.10.3 3M Nanotechnology Drug Delivery Systems Introduction
11.10.4 3M Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.10.5 3M Recent Development
11.11 Zosano Pharma
11.11.1 Zosano Pharma Company Details
11.11.2 Zosano Pharma Business Overview
11.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Introduction
11.11.4 Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.11.5 Zosano Pharma Recent Development
11.12 Becton-Dickinson（BD）Technologies
11.12.1 Becton-Dickinson（BD）Technologies Company Details
11.12.2 Becton-Dickinson（BD）Technologies Business Overview
11.12.3 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Introduction
11.12.4 Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.12.5 Becton-Dickinson（BD）Technologies Recent Development
11.13 Nanopass Technologies
11.13.1 Nanopass Technologies Company Details
11.13.2 Nanopass Technologies Business Overview
11.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Introduction
11.13.4 Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.13.5 Nanopass Technologies Recent Development
11.14 Corium
11.14.1 Corium Company Details
11.14.2 Corium Business Overview
11.14.3 Corium Nanotechnology Drug Delivery Systems Introduction
11.14.4 Corium Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.14.5 Corium Recent Development
11.15 Valeritas
11.15.1 Valeritas Company Details
11.15.2 Valeritas Business Overview
11.15.3 Valeritas Nanotechnology Drug Delivery Systems Introduction
11.15.4 Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.15.5 Valeritas Recent Development
11.16 Nitto
11.16.1 Nitto Company Details
11.16.2 Nitto Business Overview
11.16.3 Nitto Nanotechnology Drug Delivery Systems Introduction
11.16.4 Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.16.5 Nitto Recent Development
11.17 Microdermics
11.17.1 Microdermics Company Details
11.17.2 Microdermics Business Overview
11.17.3 Microdermics Nanotechnology Drug Delivery Systems Introduction
11.17.4 Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.17.5 Microdermics Recent Development
11.18 TheraJect
11.18.1 TheraJect Company Details
11.18.2 TheraJect Business Overview
11.18.3 TheraJect Nanotechnology Drug Delivery Systems Introduction
11.18.4 TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.18.5 TheraJect Recent Development
11.19 Vaxxas
11.19.1 Vaxxas Company Details
11.19.2 Vaxxas Business Overview
11.19.3 Vaxxas Nanotechnology Drug Delivery Systems Introduction
11.19.4 Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.19.5 Vaxxas Recent Development
11.20 Lohmann Therapie-Systeme AG
11.20.1 Lohmann Therapie-Systeme AG Company Details
11.20.2 Lohmann Therapie-Systeme AG Business Overview
11.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Introduction
11.20.4 Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)
11.20.5 Lohmann Therapie-Systeme AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Amgen Inc
Celgene Corporation
Johnson & Johnson
Merck& Co. Inc
Novartis International AG
Perrigo Company plc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
List of Tables
 Table 1. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Nanocrystals
 Table 3. Key Players of Nanoparticles
 Table 4. Key Players of Dendrimers
 Table 5. Key Players of Gold Nanoparticles
 Table 6. Key Players of Fullerenes
 Table 7. Key Players of Liposomes
 Table 8. Key Players of Nanotubes
 Table 9. Global Nanotechnology Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Nanotechnology Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Nanotechnology Drug Delivery Systems Market Share by Region (2020-2025)
 Table 13. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Nanotechnology Drug Delivery Systems Market Share by Region (2026-2031)
 Table 15. Nanotechnology Drug Delivery Systems Market Trends
 Table 16. Nanotechnology Drug Delivery Systems Market Drivers
 Table 17. Nanotechnology Drug Delivery Systems Market Challenges
 Table 18. Nanotechnology Drug Delivery Systems Market Restraints
 Table 19. Global Nanotechnology Drug Delivery Systems Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Nanotechnology Drug Delivery Systems Market Share by Players (2020-2025)
 Table 21. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2024)
 Table 22. Ranking of Global Top Nanotechnology Drug Delivery Systems Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Nanotechnology Drug Delivery Systems Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Nanotechnology Drug Delivery Systems, Headquarters and Area Served
 Table 25. Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application
 Table 26. Global Key Players of Nanotechnology Drug Delivery Systems, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Nanotechnology Drug Delivery Systems Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2020-2025)
 Table 30. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2026-2031)
 Table 32. Global Nanotechnology Drug Delivery Systems Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2020-2025)
 Table 34. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2026-2031)
 Table 36. North America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 51. AbbVie, Inc. Company Details
 Table 52. AbbVie, Inc. Business Overview
 Table 53. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product
 Table 54. AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 55. AbbVie, Inc. Recent Development
 Table 56. Amgen Inc. Company Details
 Table 57. Amgen Inc. Business Overview
 Table 58. Amgen Inc. Nanotechnology Drug Delivery Systems Product
 Table 59. Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 60. Amgen Inc. Recent Development
 Table 61. Celgene Corporation Company Details
 Table 62. Celgene Corporation Business Overview
 Table 63. Celgene Corporation Nanotechnology Drug Delivery Systems Product
 Table 64. Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 65. Celgene Corporation Recent Development
 Table 66. Johnson & Johnson Company Details
 Table 67. Johnson & Johnson Business Overview
 Table 68. Johnson & Johnson Nanotechnology Drug Delivery Systems Product
 Table 69. Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 70. Johnson & Johnson Recent Development
 Table 71. Merck & Co., Inc. Company Details
 Table 72. Merck & Co., Inc. Business Overview
 Table 73. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product
 Table 74. Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 75. Merck & Co., Inc. Recent Development
 Table 76. Novartis International AG Company Details
 Table 77. Novartis International AG Business Overview
 Table 78. Novartis International AG Nanotechnology Drug Delivery Systems Product
 Table 79. Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 80. Novartis International AG Recent Development
 Table 81. Perrigo Company plc Company Details
 Table 82. Perrigo Company plc Business Overview
 Table 83. Perrigo Company plc Nanotechnology Drug Delivery Systems Product
 Table 84. Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 85. Perrigo Company plc Recent Development
 Table 86. Pfizer, Inc. Company Details
 Table 87. Pfizer, Inc. Business Overview
 Table 88. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product
 Table 89. Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 90. Pfizer, Inc. Recent Development
 Table 91. Teva Pharmaceutical Industries Ltd. Company Details
 Table 92. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 93. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product
 Table 94. Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 95. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 96. 3M Company Details
 Table 97. 3M Business Overview
 Table 98. 3M Nanotechnology Drug Delivery Systems Product
 Table 99. 3M Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 100. 3M Recent Development
 Table 101. Zosano Pharma Company Details
 Table 102. Zosano Pharma Business Overview
 Table 103. Zosano Pharma Nanotechnology Drug Delivery Systems Product
 Table 104. Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 105. Zosano Pharma Recent Development
 Table 106. Becton-Dickinson（BD）Technologies Company Details
 Table 107. Becton-Dickinson（BD）Technologies Business Overview
 Table 108. Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Product
 Table 109. Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 110. Becton-Dickinson（BD）Technologies Recent Development
 Table 111. Nanopass Technologies Company Details
 Table 112. Nanopass Technologies Business Overview
 Table 113. Nanopass Technologies Nanotechnology Drug Delivery Systems Product
 Table 114. Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 115. Nanopass Technologies Recent Development
 Table 116. Corium Company Details
 Table 117. Corium Business Overview
 Table 118. Corium Nanotechnology Drug Delivery Systems Product
 Table 119. Corium Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 120. Corium Recent Development
 Table 121. Valeritas Company Details
 Table 122. Valeritas Business Overview
 Table 123. Valeritas Nanotechnology Drug Delivery Systems Product
 Table 124. Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 125. Valeritas Recent Development
 Table 126. Nitto Company Details
 Table 127. Nitto Business Overview
 Table 128. Nitto Nanotechnology Drug Delivery Systems Product
 Table 129. Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 130. Nitto Recent Development
 Table 131. Microdermics Company Details
 Table 132. Microdermics Business Overview
 Table 133. Microdermics Nanotechnology Drug Delivery Systems Product
 Table 134. Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 135. Microdermics Recent Development
 Table 136. TheraJect Company Details
 Table 137. TheraJect Business Overview
 Table 138. TheraJect Nanotechnology Drug Delivery Systems Product
 Table 139. TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 140. TheraJect Recent Development
 Table 141. Vaxxas Company Details
 Table 142. Vaxxas Business Overview
 Table 143. Vaxxas Nanotechnology Drug Delivery Systems Product
 Table 144. Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 145. Vaxxas Recent Development
 Table 146. Lohmann Therapie-Systeme AG Company Details
 Table 147. Lohmann Therapie-Systeme AG Business Overview
 Table 148. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product
 Table 149. Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)
 Table 150. Lohmann Therapie-Systeme AG Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Nanotechnology Drug Delivery Systems Picture
 Figure 2. Global Nanotechnology Drug Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nanotechnology Drug Delivery Systems Market Share by Type: 2024 VS 2031
 Figure 4. Nanocrystals Features
 Figure 5. Nanoparticles Features
 Figure 6. Dendrimers Features
 Figure 7. Gold Nanoparticles Features
 Figure 8. Fullerenes Features
 Figure 9. Liposomes Features
 Figure 10. Nanotubes Features
 Figure 11. Others Features
 Figure 12. Global Nanotechnology Drug Delivery Systems Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Nanotechnology Drug Delivery Systems Market Share by Application: 2024 VS 2031
 Figure 14. Immunology Case Studies
 Figure 15. Cardiovascular Case Studies
 Figure 16. Neurology Case Studies
 Figure 17. Oncology Case Studies
 Figure 18. Others Case Studies
 Figure 19. Nanotechnology Drug Delivery Systems Report Years Considered
 Figure 20. Global Nanotechnology Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Nanotechnology Drug Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Nanotechnology Drug Delivery Systems Market Share by Region: 2024 VS 2031
 Figure 23. Global Nanotechnology Drug Delivery Systems Market Share by Players in 2024
 Figure 24. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2024)
 Figure 25. The Top 10 and 5 Players Market Share by Nanotechnology Drug Delivery Systems Revenue in 2024
 Figure 26. North America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)
 Figure 28. United States Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)
 Figure 32. Germany Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Nanotechnology Drug Delivery Systems Market Share by Region (2020-2031)
 Figure 40. China Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)
 Figure 48. Mexico Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)
 Figure 52. Turkey Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. AbbVie, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 56. Amgen Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 57. Celgene Corporation Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 58. Johnson & Johnson Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 59. Merck & Co., Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 60. Novartis International AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 61. Perrigo Company plc Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 62. Pfizer, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 64. 3M Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 65. Zosano Pharma Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 66. Becton-Dickinson（BD）Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 67. Nanopass Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 68. Corium Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 69. Valeritas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 70. Nitto Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 71. Microdermics Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 72. TheraJect Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 73. Vaxxas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 74. Lohmann Therapie-Systeme AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nano Pharmaceutical Market Research Report 2024
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Proton Therapy Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Smart Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Robotic Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions